Literature DB >> 26130359

RhBMP-7 for the treatment of nonunion of fractures of long bones.

M Papanagiotou1, Z H Dailiana1, T Karachalios1, S Varitimidis1, M Vlychou1, M Hantes1, K N Malizos1.   

Abstract

We report the outcome of 84 nonunions involving long bones which were treated with rhBMP-7, in 84 patients (60 men: 24 women) with a mean age 46 years (18 to 81) between 2003 and 2011. The patients had undergone a mean of three previous operations (one to 11) for nonunion which had been present for a mean of 17 months (4 months to 20 years). The nonunions involved the lower limb in 71 patients and the remainder involved the upper limb. A total of 30 nonunions were septic. Treatment was considered successful when the nonunion healed without additional procedures. The relationship between successful union and the time to union was investigated and various factors including age and gender, the nature of the nonunion (location, size, type, chronicity, previous procedures, infection, the condition of the soft tissues) and type of index procedure (revision of fixation, type of graft, amount of rhBMP-7) were analysed. The improvement of the patients' quality of life was estimated using the Short Form (SF) 12 score. A total of 68 nonunions (80.9%) healed with no need for further procedures at a mean of 5.4 months (3 to 10) post-operatively. Multivariate logistic regression analysis of the factors affecting union suggested that only infection significantly affected the rate of union (p = 0.004).Time to union was only affected by the number of previous failed procedures (p = 0.006). An improvement of 79% and 32.2% in SF-12 physical and mental score, respectively, was noted within the first post-operative year. Rh-BMP-7 combined with bone grafts, enabled healing of the nonunion and improved quality of life in about 80% of patients. Aseptic nonunions were much more likely to unite than septic ones. The number of previous failed operations significantly delayed the time to union. ©2015 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Bone Morphogenetic Protein 7; bone grafts; consolidation; infection; nonunion

Mesh:

Substances:

Year:  2015        PMID: 26130359     DOI: 10.1302/0301-620X.97B7.35089

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  8 in total

1.  Comparative study suggests that human bone morphogenetic proteins have no influence on the outcome of operative treatment of aseptic clavicle non-unions.

Authors:  Christian von Rüden; Mario Morgenstern; Jan Friederichs; Peter Augat; Simon Hackl; Alexander Woltmann; Volker Bühren; Christian Hierholzer
Journal:  Int Orthop       Date:  2016-08-13       Impact factor: 3.075

2.  Heterotopic ossification after the use of recombinant human bone morphogenetic protein-7.

Authors:  Marianthi Papanagiotou; Zoe H Dailiana; Theophilos Karachalios; Sokratis Varitimidis; Michael Hantes; Georgios Dimakopoulos; Marianna Vlychou; Konstantinos N Malizos
Journal:  World J Orthop       Date:  2017-01-18

3.  Long-term outcome following additional rhBMP-7 application in revision surgery of aseptic humeral, femoral, and tibial shaft nonunion.

Authors:  Simon Hackl; Christian Hierholzer; Jan Friederichs; Alexander Woltmann; Volker Bühren; Christian von Rüden
Journal:  BMC Musculoskelet Disord       Date:  2017-08-07       Impact factor: 2.362

4.  Topical cutaneous application of carbon dioxide via a hydrogel for improved fracture repair: results of phase I clinical safety trial.

Authors:  Takahiro Niikura; Takashi Iwakura; Takashi Omori; Sang Yang Lee; Yoshitada Sakai; Toshihiro Akisue; Keisuke Oe; Tomoaki Fukui; Takehiko Matsushita; Tomoyuki Matsumoto; Ryosuke Kuroda
Journal:  BMC Musculoskelet Disord       Date:  2019-11-25       Impact factor: 2.362

5.  Risk Factors and Consequences of Lower Extremity Fracture Nonunions in Veterans With Spinal Cord Injury.

Authors:  Bridget Sinnott; Cara Ray; Frances Weaver; Beverly Gonzalez; Elizabeth Chu; Sarah Premji; Mattie Raiford; Rachel Elam; Scott Miskevics; Stephen Parada; Laura Carbone
Journal:  JBMR Plus       Date:  2022-01-05

6.  Bone morphogenetic protein-2 provokes interleukin-18-induced human intervertebral disc degeneration.

Authors:  S Ye; B Ju; H Wang; K-B Lee
Journal:  Bone Joint Res       Date:  2016-09       Impact factor: 5.853

7.  The forgotten phase of fracture healing: The need to predict nonunion.

Authors:  A H R W Simpson
Journal:  Bone Joint Res       Date:  2017-10       Impact factor: 5.853

Review 8.  Molecular pathogenesis of fracture nonunion.

Authors:  Zi-Chuan Ding; Yi-Kai Lin; Yao-Kai Gan; Ting-Ting Tang
Journal:  J Orthop Translat       Date:  2018-05-31       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.